Superstring Capital Management 13F-HR Quarterly holdings report by institutional manager

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL

OMB Number:		3235-0006
Expires:	Oct 31, 2018
Estimated average burden
hours per response:		23.8

COLUMN 1	COLUMN 2	COLUMN 3	COLUMN 4	COLUMN 5			COLUMN 6	COLUMN 7	COLUMN 8
			VALUE	SHRS OR	SH/	PUT/	INVESTMENT	OTHER	VOTING AUTHORITY
NAME OF ISSUER	TITLE OF CLASS	CUSIP	(x$1000)	PRN AMT	PRN	CALL	DISCRETION	MANAGER	SOLE	SHARED	NONE
89BIO INC	COM	282559103	5,450,028	680,403	SH		SOLE		680,403	0	0
ALLAKOS INC	COM	01671P100	940,578	940,578	SH		SOLE		940,578	0	0
ALLOGENE THERAPEUTICS INC	COM	019770106	1,607,495	689,912	SH		SOLE		689,912	0	0
APOGEE THERAPEUTICS INC	COM	03770N101	1,453,117	36,928	SH		SOLE		36,928	0	0
ARCELLX INC	COMMON STOCK	03940C100	3,263,550	59,133	SH		SOLE		59,133	0	0
ARROWHEAD PHARMACEUTICALS IN	COM	04280A100	2,888,347	111,133	SH		SOLE		111,133	0	0
ATYR PHARMA INC	COM NEW	002120202	488,324	313,028	SH		SOLE		313,028	0	0
BEIGENE LTD	SPONSORED ADR	07725L102	1,784,516	12,508	SH		SOLE		12,508	0	0
BIOMEA FUSION INC	COM	09077A106	751,995	167,110	SH		SOLE		167,110	0	0
BRIDGEBIO PHARMA INC	COM	10806X102	5,568,471	219,837	SH		SOLE		219,837	0	0
CABALETTA BIO INC	COM	12674W109	1,046,415	139,895	SH		SOLE		139,895	0	0
COMPASS PATHWAYS PLC	SPONSORED ADS	20451W101	196,282	32,497	SH		SOLE		32,497	0	0
CORBUS PHARMACEUTICALS HLDGS	COM NEW	21833P301	2,555,177	56,468	SH		SOLE		56,468	0	0
CYTOKINETICS INC	COM NEW	23282W605	10,165,956	187,633	SH		SOLE		187,633	0	0
CYTOMX THERAPEUTICS INC	COM	23284F105	1,404,852	1,151,518	SH		SOLE		1,151,518	0	0
EYEPOINT PHARMACEUTICALS INC	COM NEW	30233G209	329,191	37,838	SH		SOLE		37,838	0	0
FATE THERAPEUTICS INC	COM	31189P102	1,631,341	497,360	SH		SOLE		497,360	0	0
KARYOPHARM THERAPEUTICS INC	COM	48576U106	463,719	534,485	SH		SOLE		534,485	0	0
KEROS THERAPEUTICS INC	COM	492327101	3,394,962	74,288	SH		SOLE		74,288	0	0
KURA ONCOLOGY INC	COM	50127T109	746,223	36,242	SH		SOLE		36,242	0	0
LAKESHORE BIOPHARMA CO LTD	ORDINARY SHARES	G9845F109	199,501	307,920	SH		SOLE		307,920	0	0
LEGEND BIOTECH CORP	SPONSORED ADS	52490G102	6,850,113	154,665	SH		SOLE		154,665	0	0
MARINUS PHARMACEUTICALS INC	COM NEW	56854Q200	306,377	261,861	SH		SOLE		261,861	0	0
MERSANA THERAPEUTICS INC	COM	59045L106	221,247	110,073	SH		SOLE		110,073	0	0
NEWAMSTERDAM PHARMA COMPANY	ORDINARY SHARES	N62509109	1,233,532	64,213	SH		SOLE		64,213	0	0
NKARTA INC	COM	65487U108	5,177,154	875,999	SH		SOLE		875,999	0	0
NOVOCURE LTD	ORD SHS	G6674U108	1,145,860	66,892	SH		SOLE		66,892	0	0
PEPGEN INC	COM	713317105	466,814	29,249	SH		SOLE		29,249	0	0
PERSPECTIVE THERAPEUTICS INC	COM NEW	46489V302	873,751	87,638	SH		SOLE		87,638	0	0
PYXIS ONCOLOGY INC	COMMON STOCK	747324101	1,603,506	484,443	SH		SOLE		484,443	0	0
SAVARA INC	COM	805111101	806,000	200,000	SH		SOLE		200,000	0	0
SPRUCE BIOSCIENCES INC	COM	85209E109	40,376	77,992	SH		SOLE		77,992	0	0
SPYRE THERAPEUTICS INC	COM NEW	00773J202	1,071,374	45,571	SH		SOLE		45,571	0	0
SYROS PHARMACEUTICALS INC	COM NEW	87184Q206	194,991	37,789	SH		SOLE		37,789	0	0
TANGO THERAPEUTICS INC	COM	87583X109	991,599	115,571	SH		SOLE		115,571	0	0
TERNS PHARMACEUTICALS INC	COM	880881107	6,514,051	956,542	SH		SOLE		956,542	0	0
TOURMALINE BIO INC	COM	89157D105	1,224,645	95,229	SH		SOLE		95,229	0	0
ZAI LAB LTD	ADR	98887Q104	3,729,035	215,178	SH		SOLE		215,178	0	0
ZURA BIO LTD	CLASS A ORD SHS	G9TY5A101	548,191	156,626	SH		SOLE		156,626	0	0